{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:45:18Z","timestamp":1790261118003,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"E-Da Hospital, Kaohsiung, Taiwan.","award":["EDAHS110007"],"award-info":[{"award-number":["EDAHS110007"]}]},{"name":"E-Da Hospital, Kaohsiung, Taiwan.","award":["EDAHS110007"],"award-info":[{"award-number":["EDAHS110007"]}]},{"name":"E-Da Hospital, Kaohsiung, Taiwan.","award":["EDAHS110007"],"award-info":[{"award-number":["EDAHS110007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-024-05535-8","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T07:54:37Z","timestamp":1731916477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anticholinergic use is associated with lower mortality but not increased hip fracture risk in Parkinson\u2019s disease patients: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Po-Yen","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ming","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hou","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"5535_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 2006;5:525\u201335.","journal-title":"Lancet Neurol"},{"key":"5535_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311:1670\u201383.","journal-title":"JAMA"},{"key":"5535_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/14737175.2019.1620603","volume":"19","author":"C Vitale","year":"2019","unstructured":"Vitale C, Amboni M, Erro R, et al. Parkinson\u2019s disease management and impulse control disorders: current state and future perspectives. Expert Rev Neurother. 2019;19:495\u2013508.","journal-title":"Expert Rev Neurother"},{"key":"5535_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejphar.2015.01.030","volume":"750","author":"AK Kakkar","year":"2015","unstructured":"Kakkar AK, Dahiya N. Management of parkinsons disease: current and future pharmacotherapy. Eur J Pharmacol. 2015;750:74\u201381.","journal-title":"Eur J Pharmacol"},{"key":"5535_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2019","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674\u201394.","journal-title":"J Am Geriatr Soc"},{"key":"5535_CR6","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/jgs.13543","volume":"63","author":"K Richardson","year":"2015","unstructured":"Richardson K, Bennett K, Maidment ID, Fox C, Smithard D, Kenny RA. Use of medications with anticholinergic activity and self-reported Injurious Falls in Older Community-Dwelling adults. J Am Geriatr Soc. 2015;63:1561\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"5535_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S1041610202008505","volume":"14","author":"D Aizenberg","year":"2002","unstructured":"Aizenberg D, Sigler M, Weizman A, Barak Y. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr. 2002;14:307\u201310.","journal-title":"Int Psychogeriatr"},{"key":"5535_CR8","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/ggi.13486","volume":"18","author":"E Kose","year":"2018","unstructured":"Kose E, Hirai T, Seki T. Anticholinergic drugs use and risk of hip fracture in geriatric patients. Geriatr Gerontol Int. 2018;18:1340\u20134.","journal-title":"Geriatr Gerontol Int"},{"key":"5535_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40266-015-0298-1","volume":"32","author":"ZA Marcum","year":"2015","unstructured":"Marcum ZA, Wirtz HS, Pettinger M, et al. Anticholinergic medication use and fractures in Postmenopausal women: findings from the women\u2019s Health Initiative. Drugs Aging. 2015;32:755\u201363.","journal-title":"Drugs Aging"},{"key":"5535_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/aje\/kwp266","volume":"170","author":"SE Bentler","year":"2009","unstructured":"Bentler SE, Liu L, Obrizan M, et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol. 2009;170:1290\u20139.","journal-title":"Am J Epidemiol"},{"key":"5535_CR11","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00198-017-3909-3","volume":"28","author":"G Ballane","year":"2017","unstructured":"Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int. 2017;28:1531\u201342.","journal-title":"Osteoporos Int"},{"key":"5535_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.parkreldis.2012.01.014","volume":"18","author":"YY Chen","year":"2012","unstructured":"Chen YY, Cheng PY, Wu SL, Lai CH. Parkinson\u2019s disease and risk of hip fracture: an 8-year follow-up study in Taiwan. Parkinsonism Relat Disord. 2012;18:506\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"5535_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jamda.2018.08.014","volume":"20","author":"SB Park","year":"2019","unstructured":"Park SB, Chung CK, Lee JY, Lee JY, Kim J. Risk factors for vertebral, hip, and femoral fractures among patients with Parkinson\u2019s Disease: a 5-Year follow-up in Korea. J Am Med Dir Assoc. 2019;20:617\u201323.","journal-title":"J Am Med Dir Assoc"},{"key":"5535_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3389\/fnins.2019.01309","volume":"13","author":"J Lopez-Alvarez","year":"2019","unstructured":"Lopez-Alvarez J, Sevilla-Llewellyn-Jones J, Aguera-Ortiz L. Anticholinergic drugs in geriatric psychopharmacology. Front Neurosci. 2019;13:1309.","journal-title":"Front Neurosci"},{"key":"5535_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/0891988718757370","volume":"31","author":"ME Machado-Duque","year":"2018","unstructured":"Machado-Duque ME, Castano-Montoya JP, Medina-Morales DA, Castro-Rodriguez A, Gonzalez-Montoya A, Machado-Alba JE. Drugs with anticholinergic potential and risk of Falls with hip fracture in the Elderly patients: a case-control study. J Geriatr Psychiatry Neurol. 2018;31:63\u20139.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"5535_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1177\/1060028014535363","volume":"48","author":"LA Fraser","year":"2014","unstructured":"Fraser LA, Adachi JD, Leslie WD, et al. Effect of anticholinergic medications on Falls, fracture risk, and bone Mineral Density over a 10-Year period. Ann Pharmacother. 2014;48:954\u201361.","journal-title":"Ann Pharmacother"},{"key":"5535_CR17","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1592\/phco.2005.25.11.1592","volume":"25","author":"KM Rudd","year":"2005","unstructured":"Rudd KM, Raehl CL, Bond CA, Abbruscato TJ, Stenhouse AC. Methods for assessing drug-related anticholinergic activity. Pharmacotherapy. 2005;25:1592\u2013601.","journal-title":"Pharmacotherapy"},{"key":"5535_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/j.1532-5415.1995.tb07396.x","volume":"43","author":"ME Tinetti","year":"1995","unstructured":"Tinetti ME, Doucette J, Claus E, Marottoli R. Risk factors for serious injury during falls by older persons in the community. J Am Geriatr Soc. 1995;43:1214\u201321.","journal-title":"J Am Geriatr Soc"},{"key":"5535_CR19","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jamda.2020.11.021","volume":"22","author":"HG Seo","year":"2021","unstructured":"Seo HG, Byun SJ, Oh BM, Park SJ. Ten-year relative survival from the diagnosis of Parkinson\u2019s Disease: a Nationwide Database Study. J Am Med Dir Assoc. 2021;22:1757\u201361.","journal-title":"J Am Med Dir Assoc"},{"key":"5535_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fneur.2018.00627","volume":"9","author":"C Eggers","year":"2018","unstructured":"Eggers C, Dano R, Schill J, et al. Access to End-of Life Parkinson\u2019s Disease patients through patient-centered Integrated Healthcare. Front Neurol. 2018;9:627.","journal-title":"Front Neurol"},{"key":"5535_CR21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1080\/03007995.2021.1954895","volume":"37","author":"H Senderovich","year":"2021","unstructured":"Senderovich H, Jimenez Lopez B. Integration of palliative care in Parkinson\u2019s disease management. Curr Med Res Opin. 2021;37:1745\u201359.","journal-title":"Curr Med Res Opin"},{"key":"5535_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jfma.2015.05.014","volume":"115","author":"WM Liu","year":"2016","unstructured":"Liu WM, Wu RM, Lin JW, Liu YC, Chang CH, Lin CH. Time trends in the prevalence and incidence of Parkinson\u2019s disease in Taiwan: a nationwide, population-based study. J Formos Med Assoc. 2016;115:531\u20138.","journal-title":"J Formos Med Assoc"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05535-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T08:03:45Z","timestamp":1731917025000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05535-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5535"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05535-8","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"21 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the Institutional Review Board (IRB) of E-Da Hospital, under the reference number IRB EMRP108-061. The committee provided ethical approval for the research protocol, ensuring that the study complies with the ethical standards for research involving human participants. This approval encompasses all aspects of the study, affirming our commitment to conducting research ethically and responsibly. The requirement for participant consent was deemed unnecessary by the Ethics Committee of the Institutional Review Board of E-Da Hospital due to the following reasons: the data for this study was sourced from the Taiwan National Health Insurance Database, which contains de-identified or anonymized data. This ensures the privacy and confidentiality of individual patients. According to the regulations and laws governing data privacy and protection in Taiwan, research utilizing such de-identified data does not necessitate direct informed consent from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"961"}}